Literature DB >> 18458817

(99m)Tc-Tetrofosmin brain SPECT in the assessment of meningiomas-correlation with histological grade and proliferation index.

Andreas D Fotopoulos1, George A Alexiou, Ann Goussia, Athanasios Papadopoulos, Athanasios P Kyritsis, Konstantinos S Polyzoidis, Spyridon Voulgaris, Spyridon Tsiouris.   

Abstract

Meningiomas account for about 30% of all intracranial tumors. Evaluation of their proliferation rate is useful for assessing their biological behavior. We evaluated prospectively whether (99m)Tc-Tetrofosmin ((99m)Tc-TF) uptake in meningiomas correlates with cellular proliferative activity and with tumor grade. We prospectively studied 18 meningioma cases. Brain single-photon emission computed tomography (SPECT) by (99m)Tc-TF was performed within a week prior to surgical excision. In the excised tumor specimens we assessed Ki-67 antigen expression. 14 of 18 patients had benign meningiomas, while the remaining four had anaplastic meningiomas. A significant correlation was found between both (99m)Tc-TF uptake and tumor grade (r = 0.722, P = 0.001) and between (99m)Tc-TF uptake and Ki-67 expression (r = 0.930, P < 0.001). There was a significant correlation between the intensity of tracer uptake and tumor recurrence at 1 year postoperative (r = 0.574, P = 0.02). This pilot study implies that (99m)Tc-TF brain SPECT could prove useful in differentiating benign from anaplastic meningiomas and is a potential indicator of their proliferative activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458817     DOI: 10.1007/s11060-008-9611-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  49 in total

1.  Involvement of the glutathione S-conjugate compounds and the MRP protein in Tc-99m-tetrofosmin and Tc-99m-sestamibi uptake in glioma cell lines.

Authors:  N Perek; N Prevot; F Koumanov; D Frere; O Sabido; P Beauchesne; F Dubois
Journal:  Nucl Med Biol       Date:  2000-04       Impact factor: 2.408

2.  Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling.

Authors:  M Shibuya; T Hoshino; S Ito; M R Wacker; M D Prados; R L Davis; C B Wilson
Journal:  Neurosurgery       Date:  1992-04       Impact factor: 4.654

3.  The utility of MIB-1/Ki-67 immunostaining in the evaluation of central nervous system neoplasms.

Authors:  Richard A Prayson
Journal:  Adv Anat Pathol       Date:  2005-05       Impact factor: 3.875

4.  Glucose and methionine uptake and proliferative activity in meningiomas.

Authors:  T Iuchi; Y Iwadate; H Namba; K Osato; N Saeki; A Yamaura; Y Uchida
Journal:  Neurol Res       Date:  1999-10       Impact factor: 2.448

5.  Progesterone and estrogen receptors in meningiomas: prognostic considerations.

Authors:  D W Hsu; J T Efird; E T Hedley-Whyte
Journal:  J Neurosurg       Date:  1997-01       Impact factor: 5.115

6.  The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome.

Authors:  Fazilet Kayaselçuk; Suzan Zorludemir; Nebil Bal; Bulent Erdogan; Seyda Erdogan; Tahsin Erman
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

7.  Different thallium-201 single-photon emission tomographic patterns in benign and aggressive meningiomas.

Authors:  E Tedeschi; A Soricelli; A Brunetti; M Romano; A Bucciero; G Iaconetta; A Alfieri; A Postiglione; M Salvatore
Journal:  Eur J Nucl Med       Date:  1996-11

8.  Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index.

Authors:  S W Coons; P C Johnson
Journal:  J Neuropathol Exp Neurol       Date:  1993-11       Impact factor: 3.685

9.  Incidental meningiomas in autopsy study.

Authors:  S Nakasu; A Hirano; T Shimura; J F Llena
Journal:  Surg Neurol       Date:  1987-04

10.  Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.

Authors:  K Onda; R L Davis; M Shibuya; C B Wilson; T Hoshino
Journal:  Cancer       Date:  1994-10-01       Impact factor: 6.860

View more
  9 in total

Review 1.  Update on meningiomas.

Authors:  Santosh Saraf; Bridget J McCarthy; J Lee Villano
Journal:  Oncologist       Date:  2011-10-25

2.  Technetium Tc99m-tetrofosmin brain single-photon emission CT for the diagnosis of malignant meningiomas.

Authors:  G A Alexiou; S Voulgaris; S Tsiouris; A D Fotopoulos; A P Kyritsis; K S Polyzoidis
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-04       Impact factor: 3.825

3.  99mTc-tetrofosmin SPECT for glioma evaluation.

Authors:  George A Alexiou; Spyridon Tsiouris; Athanasios P Kyritsis; Spyridon Voulgaris; Konstantinos S Polyzoidis; Andreas D Fotopoulos
Journal:  Mol Imaging Biol       Date:  2009-03-27       Impact factor: 3.488

4.  Influence of glioma's multidrug resistance phenotype on (99m)Tc-tetrofosmin uptake.

Authors:  George A Alexiou; Anna Goussia; Athanasios P Kyritsis; Spyridon Tsiouris; Antigoni Ntoulia; Vassiliki Malamou-Mitsi; Spyridon Voulgaris; Andreas D Fotopoulos
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

5.  Characterization of intracranial space-occupying lesions by ⁹⁹(m)Tc-Tetrofosmin SPECT.

Authors:  Andreas D Fotopoulos; Athanasios P Kyritsis; Spyridon Tsiouris; Jihad Al-Boucharali; Athanasios Papadopoulos; Spyridon Voulgaris; George A Alexiou
Journal:  J Neurooncol       Date:  2010-05-23       Impact factor: 4.130

Review 6.  Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities.

Authors:  George A Alexiou; Spyridon Tsiouris; Athanasios P Kyritsis; Spyridon Voulgaris; Maria I Argyropoulou; Andreas D Fotopoulos
Journal:  J Neurooncol       Date:  2009-04-21       Impact factor: 4.130

7.  SPECT and PET imaging of meningiomas.

Authors:  Varvara Valotassiou; Anastasia Leondi; George Angelidis; Dimitrios Psimadas; Panagiotis Georgoulias
Journal:  ScientificWorldJournal       Date:  2012-05-01

Review 8.  Progress on the diagnosis and evaluation of brain tumors.

Authors:  Huile Gao; Xinguo Jiang
Journal:  Cancer Imaging       Date:  2013-12-11       Impact factor: 3.909

9.  Magnetic Resonance Spectroscopy and Single-Photon Emission Computed Tomography in the Evaluation of Cerebral Tumors: A Case Report.

Authors:  Ioannis Siasios; Varvara Valotassiou; Eftychia Kapsalaki; Ioannis Tsougos; Panagiotis Georgoulias; Aggeliki Fotiadou; Maria Ioannou; Georgios Koukoulis; Vassilios Dimopoulos; Kostas Fountas
Journal:  J Clin Med Res       Date:  2016-11-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.